Among the safety stocks discussed by Cramer during the episode on May 14, Bristol-Myers Squibb Company (NYSE:BMY) was first ...

Bristol-Myers Squibb Co. prevailed against investor allegations it misled them about a payout tied to Food and Drug Administration approval of cancer treatments by acquired company Celgene Corp., an ...

Although the Trump administration's healthcare policies pose risks for Bristol-Myers Squibb, the chaos opens a contrarian door for BMY stock.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE ...

It's no secret that brand-name drugs in the U.S. are much more expensive than they are abroad. In the spirit of fairness, the ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

My shift schedule allowed me to allocate time to complete my third-level education - a biopharmaceutical processing degree at ...

Shares of Bristol Myers Squibb Co. BMY shed 1.01% to $50.06 Monday, on what proved to be an all-around grim trading session ...

In patients with venous thromboembolism (VTE) who are candidates for oral anticoagulation, apixaban results in fewer ...